Related references
Note: Only part of the references are listed.Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53
Jian Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose
Yao Cheng et al.
BIOMEDICAL REPORTS (2014)
FSHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein
Aline Awad et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
Ubiquitin-Proteasome Pathway and Prostate Cancer
Fang-Zhi Chen et al.
ONKOLOGIE (2013)
Hepatitis B virus-induced hepatocellular carcinoma: The role of the virus x protein
M. Motavaf et al.
ACTA VIROLOGICA (2013)
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
Te-Chun Hsia et al.
MOLECULAR PHARMACOLOGY (2013)
Skp2: A novel potential therapeutic target for prostate cancer
Zhiwei Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
Gwenny M. Fuhler et al.
MOLECULAR MEDICINE (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKKβ to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
Chia-Jui Yen et al.
PLOS ONE (2012)
Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent
Shuo Wei et al.
PLOS ONE (2012)
Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability
William's Elong Edimo et al.
BIOCHEMICAL JOURNAL (2011)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21
Yuehua Huang et al.
GASTROENTEROLOGY (2011)
SHIP2 Multiple Functions: A Balance Between a Negative Control of PtdIns(3,4,5)P3 Level, a Positive Control of PtdIns(3,4)P2 Production, and Intrinsic Docking Properties
Christophe Erneux et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection
Samuel Martin-Vilchez et al.
REVIEWS IN MEDICAL VIROLOGY (2011)
SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo
Michael J. Jurynec et al.
DISEASE MODELS & MECHANISMS (2010)
Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes
Akira Suwa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2
Jia Yu et al.
FASEB JOURNAL (2010)
Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
Chia-Hsin Chan et al.
THESCIENTIFICWORLDJOURNAL (2010)
The Natural History of Chronic Hepatitis B Virus Infection
Brian J. McMahon
HEPATOLOGY (2009)
SHIP2 (SH2 Domain-containing Inositol Phosphatase 2) SH2 Domain Negatively Controls SHIP2 Monoubiquitination in Response to Epidermal Growth Factor
Julie De Schutter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells
Nagendra K. Prasad
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
The tumor suppressor activity of IKKα in stratified epithelia is exerted in part via the TGF-β anti proliferative pathway
Barbara Marinari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover
Nagendra K. Prasad et al.
CARCINOGENESIS (2008)
Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain-containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice -: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis
Rolf Grempler et al.
DIABETES (2007)
Hepatitis B virus X protein differentially affects the ubiquitin-mediated proteasomal degradation of β-catenin depending on the status of cellular p53
Jin Kyu Jung et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma
J Liu et al.
ONCOGENE (2006)
The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc
N Kalra et al.
FEBS LETTERS (2006)
2-NBDG as a fluorescent indicator for direct glucose uptake measurement
CH Zou et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2005)
Global control of hepatitis B virus infection
JH Kao et al.
LANCET INFECTIOUS DISEASES (2002)
Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression
AC Carrano et al.
JOURNAL OF CELL BIOLOGY (2001)
Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity
T Wada et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The lipid phosphatase SHIP2 controls insulin sensitivity
S Clément et al.
NATURE (2001)
5 ' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells
V Taylor et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
